Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ephrin-B3 is a cell surface transmembrane ligand for Eph receptors, the largest subfamily of receptor tyrosine kinases. Ephrin-B3 plays crucial roles in bidirectional cell signaling, especially during neural, vascular, and epithelial development. The protein is encoded by the EFNB3 gene and contains a transmembrane domain with a cytoplasmic tail that enables reverse signaling through phosphorylation and PDZ protein interactions. Ephrin-B3 participates in axon guidance, neurogenesis, synaptic plasticity, and has pivotal functions in the forebrain and other nervous system regions. Additionally, Ephrin-B3 can act as a receptor for Nipah and Hendra viruses. Dysfunction or alteration of EFNB3 signaling is implicated in diseases including craniofrontonasal syndrome, encephalitis, and potentially cancer or neurodevelopmental disorders.
Theoretical mechanisms include inhibitors or modulators of ephrin/Eph receptor interaction and signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ephrin-B3 (EFNB3).